Abiraterone acetate base comprehensive for treatment of oligometastatic hormone-sensitive prostate cancer: a case report and literature review
10.3760/cma.j.cn112330-20210408-00010
- VernacularTitle:寡转移激素敏感性前列腺癌综合治疗一例报告并文献复习
- Author:
Jian CAO
1
;
Gongqian ZENG
;
Shusuan JIANG
;
Yu XIE
;
Weiqing HAN
Author Information
1. 湖南省肿瘤医院泌尿外科 中南大学湘雅医学院附属肿瘤医院，长沙 410007
- Keywords:
Prostate cancer;
Oligometastatic;
Hormone-sensitive;
Androgen deprivation therapy;
Abiraterone acetate;
Palliative transurethral resection of the prostate
- From:
Chinese Journal of Urology
2021;42(Z1):39-42
- CountryChina
- Language:Chinese
-
Abstract:
Conclusion:Patients with OlimHSPC who are not sensitive to traditional CAB treatment, ADT combined with abiraterone acetate neoadjuvant therapy and postoperative adjuvant therapy can be attempted.
